CN112603957A - Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof - Google Patents

Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof Download PDF

Info

Publication number
CN112603957A
CN112603957A CN202110034417.XA CN202110034417A CN112603957A CN 112603957 A CN112603957 A CN 112603957A CN 202110034417 A CN202110034417 A CN 202110034417A CN 112603957 A CN112603957 A CN 112603957A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
rhizome
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110034417.XA
Other languages
Chinese (zh)
Inventor
谭秀波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110034417.XA priority Critical patent/CN112603957A/en
Publication of CN112603957A publication Critical patent/CN112603957A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The invention provides a traditional Chinese medicine for treating hyperosteogeny, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine for treating the hyperosteogeny is prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials. The components in the traditional Chinese medicine formula prepared by the invention are mutually cooperated and play a role together, so that the prepared traditional Chinese medicine can relieve pain and has a better treatment effect, and the components used in the formula are all relatively cheap medicinal materials, so that the treatment expense of a patient can be reduced.

Description

Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating hyperosteogeny and a preparation method thereof.
Background
In the modern society, the rhythm of life is fast, and people are under tension and pressure, so that proliferative osteoarthropathy such as neck, shoulder, waist, leg and the like becomes common diseases, and the proliferative osteoarthropathy is also called as hyperosteogeny. Hyperosteogeny is a common frequently-occurring disease in clinic, mainly because the long-term abrasion of joints causes the hyperplasia and traction of ligaments around the joints, and normal sclerotin around the joints is gradually increased. It is also called hyperplasia, hypertrophic or degenerative arthritis, and refers to chronic arthropathy caused by the destruction of joint cartilage due to joint degeneration. The disease is better at cervical vertebra, lumbar vertebra, hip, knee, and root bone, and can occur singly or frequently.
The pathogenic factors of this disease are usually the accumulation of blood stasis and the accumulation of pathogen without dispersing, and are usually caused by liver and kidney deficiency, essence and blood deficiency or wind-cold-dampness pathogen entering due to deficiency, qi-blood obstruction, and malnutrition of muscles and bones. The existing common means are (1) surgical excision, the pain of a patient is large, the cost is high, the wound of the affected joint is large, and hyperosteogeny is formed in the process of wound repair; (2) the medical treatment course is long, and the treatment is temporary and permanent; (3) the massage or physical therapy is painful and ineffective for the patient. Therefore, a treatment means with less pain, low cost and good treatment effect is urgently needed.
Disclosure of Invention
The invention aims to provide the traditional Chinese medicine for treating the hyperosteogeny, and the traditional Chinese medicine for treating the hyperosteogeny has the advantages of small pain, low cost and good treatment effect.
The invention also aims to provide a preparation method of the traditional Chinese medicine for treating the hyperosteogeny so as to obtain the traditional Chinese medicine for treating the hyperosteogeny with good treatment effect.
The technical problem to be solved by the invention is realized by adopting the following technical scheme.
On one hand, the embodiment of the application provides a traditional Chinese medicine for treating hyperosteogeny, which is prepared from the following raw material medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
On the other hand, the embodiment of the application also provides a preparation method of the traditional Chinese medicine for treating the hyperosteogeny, which specifically comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
The clematis root is pungent, salty and warm in taste, has the functions of entering bladder channel, dispelling wind and removing dampness, and dredging collaterals and relieving pain, and is used for treating rheumatic arthralgia, numbness of limbs, spasm of muscles and vessels, difficulty in flexion and extension, and choking throat.
Radix Saposhnikoviae is pungent, sweet and warm in flavor, has effects of entering bladder, liver and spleen channels, relieving exterior syndrome, dispelling pathogenic wind, eliminating dampness, and relieving spasm, and can be used for treating common cold, headache, rheumatalgia, rubella pruritus, and tetanus.
Borneol is bitter in taste and cool, has the effects of dredging orifices, dispelling stagnated fire, removing nebula and improving eyesight, and relieving swelling and pain. It is a commonly used skin penetration enhancer for treating vomiting due to apoplexy, coma due to febrile disease, epilepsy due to convulsion, phlegm coma, qi block, deafness, pharyngitis, aphtha, otitis media, carbuncle, swelling, hemorrhoid, nebula and enterobiasis.
Rhizoma Ligustici Chuanxiong has effects of promoting blood circulation, activating qi-flowing, dispelling pathogenic wind and relieving pain, contains an oily alkaloid, ferulic acid volatile oil, etc. and can paralyze nerve center, so has effects of relieving pain, relieving spasm and tranquilizing; it also has vitamin E deficiency resisting effect, and can soften hyperplastic bone.
Radix Ranunculi Ternati has effects of removing toxic substance, eliminating phlegm and resolving hard mass, and relieving swelling, and can be used for treating lymphoid tuberculosis, pharyngitis, furuncle, snake bite, malaria, migraine, and toothache.
Cortex Erythrinae has effects of relieving pain, diminishing inflammation, dispelling pathogenic wind, activating qi-flowing, eliminating dampness, and promoting blood circulation, and can be used for treating gastritis, nephritis and rheumatalgia, or for treating knife wound by external application; expelling wind-damp, dredging channels and collaterals, and killing parasites; it is indicated for wind-damp arthralgia, dysentery, toothache, scabies and tinea.
Cyrtomium fortunei, being slightly cold in nature and bitter in taste, enters liver and stomach meridians, and is used for clearing away heat and toxic material, killing parasites and stopping bleeding, belonging to the category of heat-clearing and detoxifying drugs.
The garden balsam stem is pungent in taste and warm in nature, has the effects of dispelling pathogenic wind, removing dampness, relieving rigidity of muscles, promoting blood circulation, removing blood stasis, relieving swelling, removing toxic substance and relieving eye pain, and can be used for treating rheumatalgia, tendons and bones contracture, cold dampness loempe, waist sprain, paralysis, amenorrhea, eczema of scrotum, skin ulcer, furuncle, and pyogenic infections.
The Sichuan pepper is pungent in flavor, warm, hot, toxic, pathogenic qi cough, middle-jiao warming, bone joint and skin dead muscle removing, cold-dampness arthralgia, qi descending, six fu-organ cold removing, typhoid fever, malaria, strong wind and sweat, retained food in the heart and abdomen, intestinal diarrhea, essence excretion, female chronic breast disease, pathogenic wind dispersing, abdominal mass, edema, yellow gall, chronic fever, and toxic parasites killing and fish poison. If the medicine is taken for a long time, the head is not white, and the body is lightened and the life is prolonged. It can be used as plaster for opening striae, promoting blood circulation, strengthening teeth and hair, regulating joint function, and resisting cold and summer heat.
The peel is pungent and warm in flavor. Has little toxicity. Has effects in expelling pathogenic wind, dispelling cold, removing toxic materials, and relieving pain. Can be used for treating rheumatism, osteodynia, traumatic injury, toothache, and venomous snake bite.
Artificial musk is pungent in flavor and warm in nature, enters heart and spleen channels, has the functions of inducing resuscitation and refreshing mind, and is capable of activating blood and resolving masses, and inducing parturition and getting fetus down. Can remove blood stasis, has the functions of promoting blood circulation to disperse stagnation, and relieving swelling and pain, and is often combined with toxicity-removing and blood-activating herbs to be taken orally or externally applied to sore and furuncle pyogenic infections; it can be used for amenorrhea, traumatic injury and arthralgia, and is combined with blood-activating and stasis-resolving herbs to strengthen its blood-activating action.
The unprocessed Strychnos nux-vomica has cold nature, bitter taste and toxicity, enters liver and spleen channels, has the effects of dissipating stagnation, reducing swelling, dredging collaterals and relieving pain, and is traditionally used for treating rheumatism, obstinate paralysis, gangrene, carbuncle, gall, traumatic injury and the like.
Fructus Psoraleae has effects of invigorating bone, tonifying yang, warming spleen and relieving diarrhea, and can be used for treating symptoms such as nocturnal emission, urination reduction, kidney yin deficiency, and psychroalgia of waist and knee.
Rhizoma homalomenae has effects of dispelling pathogenic wind, removing dampness, and strengthening tendons and bones, and can be used for treating rheumatism, arthralgia and myalgia, and spasm and numbness.
Olibanum has effects in promoting blood circulation and relieving pain, and can be used for treating blood stasis, swelling and pain, spasm of tendons and collaterals, and spasm of tendons and collaterals due to arthralgia-deep-rooted carbuncle; the milk is fragrant, bitter, pungent and warm in nature, so it can dredge tendons and vessels, activate and relieve swelling and stasis, stop pain, relieve spasm and extension of tendons, relieve swelling and pain, and promote granulation.
Compared with the prior art, the embodiment of the invention has at least the following advantages or beneficial effects:
(1) the formula adopted by the invention is a traditional Chinese medicine for treating hyperosteogeny with outstanding effect obtained by the inventor through years of research and development and experiments and continuously improving the formula after long-time experiment comparative analysis, all components in the formula are mutually cooperated and play a role together, so that the prepared traditional Chinese medicine can relieve pain and has better treatment effect, and the components used in the adopted formula belong to cheaper medicinal materials, thereby simultaneously reducing the treatment expense of patients.
(2) The traditional Chinese medicine composition is scientific in composition, reasonable in compatibility and synergistic in synergy of all components according to the monarch, minister, assistant and guide principles, specifically takes clematis root, ligusticum wallichii, cyrtomium fortunei, radix ranunculi ternati, erythrina bark, garden balsam stem and fructus psoraleae as monarch drugs, plays roles of dispelling wind and removing dampness, dredging collaterals and relieving pain, relieving pain and spasm and calming, diminishing inflammation, promoting qi and activating blood, tonifying bone and tonifying yang, warming spleen and stopping diarrhea, and can be used for treating symptoms due to the fact that blood stasis and pathogen of a patient are mixed and coagulated without dispersion and damp-heat swelling; borneol, pricklyash peel, artificial musk and obscured homalomena rhizome are taken as ministerial drugs, so that the effects of relieving swelling and pain, eliminating cold-dampness and arthralgia, dispelling wind-damp and strengthening tendons and bones are achieved, and the hyperosteogeny is better treated; the raw nux vomica and the divaricate saposhnikovia root are taken as adjuvant drugs, so that the effects of eliminating rheumatism and arthralgia, eliminating stagnation and reducing swelling, and dredging collaterals and relieving pain are achieved, and the treatment effect is enhanced; the liquor and the frankincense are used as guiding drugs, and the effects of dredging the tendons and vessels, activating and diminishing swelling, removing blood stasis, and dredging the channels and activating the collaterals are achieved. The medicines are matched and supplemented with each other to achieve the effects of promoting blood circulation and promoting qi circulation, removing blood stasis and relieving pain, stretching tendons and activating collaterals, dredging collaterals and removing blood stasis and relieving pain, and dispelling internal cold and dampness to soften the bony spur, so that the hyperosteogeny is softened and the pain is relieved.
(3) The traditional Chinese medicine composition is scientific in composition, reasonable in compatibility and synergistic in synergy of all components according to the monarch, minister, assistant and guide principles, specifically takes clematis root, ligusticum wallichii, cyrtomium fortunei, radix ranunculi ternati, erythrina bark, pittosporum root, garden balsam stem and fructus psoraleae as monarch drugs, plays roles of dispelling wind and removing dampness, dredging collaterals and relieving pain, relieving pain and spasm and calming, diminishing inflammation, promoting qi and blood circulation, tonifying bones and strengthening yang, warming spleen and stopping diarrhea, and detoxifying and relieving pain, and can be used for treating symptoms by compounding the drugs due to the fact that stasis and pathogen are mixed and coagulated but not dispersed, and damp; borneol, pricklyash peel, artificial musk and obscured homalomena rhizome are taken as ministerial drugs, so that the effects of relieving swelling and pain, eliminating cold-dampness and arthralgia, dispelling wind-damp and strengthening tendons and bones are achieved, and the hyperosteogeny is better treated; the raw nux vomica and the divaricate saposhnikovia root are taken as adjuvant drugs, so that the effects of eliminating rheumatism and arthralgia, eliminating stagnation and reducing swelling, and dredging collaterals and relieving pain are achieved, and the treatment effect is enhanced; the liquor and the frankincense are used as guiding drugs, and the effects of dredging the tendons and vessels, activating and diminishing swelling, removing blood stasis, and dredging the channels and activating the collaterals are achieved. The medicines are matched and supplemented with each other to achieve the effects of promoting blood circulation and promoting qi circulation, removing blood stasis and relieving pain, stretching tendons and activating collaterals, dredging collaterals and removing blood stasis and relieving pain, and dispelling internal cold and dampness to soften the bony spur, so that the hyperosteogeny is softened and the pain is relieved.
(4) The liquor is mixed with other medicinal materials for soaking, and after the soaking time is reached, the drug effects of various traditional Chinese medicines are mixed into the liquor, so that the liquor contains certain drug effect components, and better permeates into human body to achieve the treatment effect.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
The invention provides a traditional Chinese medicine for treating hyperosteogeny, which is prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
In detail, the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white spirit.
In detail, the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 10-30 parts of seed of Chinese wampee, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit.
In detail, the traditional Chinese medicine is prepared from the following raw materials in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 25 parts of seed of Chinese yam, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white.
In detail, the white spirit is 60-65 degree white spirit.
The invention also provides a preparation method of the traditional Chinese medicine for treating hyperosteogeny, which comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
In detail, the size of the raw medicinal powder crushed in the crushing step is 80-200 meshes.
In detail, the stirring speed of the mixing step is 70-80r/min, and the stirring time is 10-30 min.
In detail, the sealing step is to seal and store the mixture in a closed container for 3 months, open the container every 1 month, and stir the mixture in the container at a speed of 70-80r/min for 1-5 min.
The features and properties of the present invention are described in further detail below with reference to examples.
Example 1
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 50g of radix clematidis, 20g of divaricate saposhnikovia root, 20g of borneol, 30g of ligusticum wallichii, 10g of radix ranunculi ternati, 20g of erythrina bark, 25g of cyrtomium fortunei, 10g of garden balsam stem, 10g of pepper, 40g of artificial musk, 20g of raw nux vomica, 40g of fructus psoraleae, 30g of obscured homalomena rhizome, 15g of frankincense and 140g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 10min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 70r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 2
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 55g of radix clematidis, 25g of divaricate saposhnikovia root, 22g of borneol, 32g of ligusticum wallichii, 15g of radix ranunculi ternati, 22g of erythrina bark, 27g of cyrtomium fortunei, 18g of garden balsam stem, 10g of pepper, 42g of artificial musk, 25g of raw nux vomica, 43g of fructus psoraleae, 35g of obscured homalomena rhizome, 20g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 20min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 3
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 60g of radix clematidis, 30g of divaricate saposhnikovia root, 22g of borneol, 36g of ligusticum wallichii, 20g of radix ranunculi ternati, 25g of erythrina bark, 30g of cyrtomium fortunei, 23g of garden balsam stem, 12g of pepper, 43g of artificial musk, 28g of raw nux vomica, 46g of fructus psoraleae, 38g of obscured homalomena rhizome, 25g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 20min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 4
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 70g of radix clematidis, 30g of divaricate saposhnikovia root, 30g of borneol, 40g of ligusticum wallichii, 25g of radix ranunculi ternati, 30g of erythrina bark, 40g of cyrtomium fortunei, 30g of garden balsam stem, 15g of pepper, 15g of artificial musk, 35g of raw nux vomica, 50g of fructus psoraleae, 40g of obscured homalomena rhizome, 35g of frankincense and 200g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 80r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 5
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 50g of radix clematidis, 20g of divaricate saposhnikovia root, 20g of borneol, 30g of ligusticum wallichii, 10g of radix ranunculi ternati, 20g of erythrina bark, 25g of cyrtomium fortunei, 10g of garden balsam stem, 10g of pepper, 10g of Piper skinnum, 40g of artificial musk, 20g of raw nux vomica, 40g of fructus psoraleae, 30g of obscured homalomena rhizome, 15g of frankincense and 140g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 70r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at a speed of 70r/min for 3 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 6
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 55g of radix clematidis, 25g of divaricate saposhnikovia root, 25g of borneol, 33g of ligusticum wallichii, 14g of radix ranunculi ternati, 25g of erythrina bark, 27g of cyrtomium fortunei, 22g of garden balsam stem, 15g of pepper, 20g of Piper nigrum, 45g of artificial musk, 25g of raw nux vomica, 42g of fructus psoraleae, 33g of obscured homalomena rhizome, 20g of frankincense and 150g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 7
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 60g of radix clematidis, 30g of divaricate saposhnikovia root, 22g of borneol, 36g of ligusticum wallichii, 20g of radix ranunculi ternati, 25g of erythrina bark, 30g of cyrtomium fortunei, 23g of garden balsam stem, 12g of pepper, 25g of Piper nigrum, 43g of artificial musk, 28g of raw nux vomica, 46g of fructus psoraleae, 38g of obscured homalomena rhizome, 25g of frankincense and 160g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
Example 8
The traditional Chinese medicine for treating hyperosteogeny is prepared by the following steps:
weighing the medicines: weighing 70g of radix clematidis, 30g of divaricate saposhnikovia root, 28g of borneol, 40g of ligusticum wallichii, 25g of radix ranunculi ternati, 30g of erythrina bark, 40g of cyrtomium fortunei, 25g of garden balsam stem, 15g of pepper, 30g of Piper nigrum, 48g of artificial musk, 35g of raw nux vomica, 50g of fructus psoraleae, 38g of obscured homalomena rhizome, 30g of frankincense and 180g of white spirit according to the formula proportion, and removing impurities, screening, cleaning, drying and baking the medicinal materials.
Crushing: pulverizing radix Clematidis, radix Saposhnikoviae, Borneolum Syntheticum, rhizoma Ligustici Chuanxiong, radix Ranunculi Ternati, cortex Erythrinae, rhizoma Osmundae, caulis et folium Gaultheriae Yunnanensis, fructus Zanthoxyli, cortex moutan, artificial Moschus, semen Strychni, fructus Psoraleae, rhizoma homalomenae and Olibanum to obtain 80-200 mesh raw material powder;
mixing: mixing the raw material powder obtained in the crushing step with white spirit, stirring at a stirring speed of 80r/min for 30min, and uniformly stirring to obtain a mixture;
sealing: placing the mixture obtained in the mixing step in a sealed container, sealing and storing for 3 months, opening the container every 1 month, and stirring the mixture in the container at the speed of 80r/min for 5 min;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
And (3) counting clinical data:
the inventor of the present application treated 256 patients in total from 2008 to 2020. Among them, 86 cases of patients with cervical vertebra hyperosteogeny, 91 cases of patients with lumbar vertebra hyperosteogeny, 60 cases of patients with knee joint hyperosteogeny, 13 cases of patients with ankle joint hyperosteogeny, and 6 cases of patients with both lumbar joint hyperosteogeny and cervical vertebra hyperosteogeny. Wherein, 208 patients are cured, the cure rate reaches 81 percent, 27 patients are effectively relieved, and the total effective rate reaches 92 percent.
And (3) curing: the pathological symptoms disappear, the physiological function returns to normal, the reduction or elimination of the original hyperplastic tissues of the vertebral body or the bone joint is assisted to be checked, and the disease does not recur for more than half a year.
The method has the following advantages: pain, numbness or other pathological conditions are reduced, but their clinical manifestations are not completely eliminated.
Typical cases of clinical practice are as follows:
typical case 1: liu somebody, man, 45 years old, 3 months and 26 days in 2009 to see a doctor, 7 years long-term driving leads to waist gall, go to hospital to examine, and hospital X-ray diagnosis shows that waist hyperostosis, adopt the traditional Chinese medicine of this embodiment 3 to treat, paste this traditional Chinese medicine on the paster carrier, and paste this paster in the waist pain department, paste one day, paste 12h each time, 3 consecutive courses of treatment, 3 subsides of each course of treatment, 3 courses of treatment back waist are basically painless, resume normal.
Typical case 2: zhang a certain, the woman, 60 years old, 7 months 15 days of 2009 see a doctor, it is uncomfortable to have passed the age often cervical vertebra, go to the hospital inspection, it is cervical hyperostosis to diagnose through the doctor, adopt the traditional chinese medicine of this embodiment 7 to treat, paste this traditional chinese medicine on the paster carrier to paste this paster in the neck pain department, paste one day, paste 15h at every turn, 1 course of treatment is tried out earlier, it is effective to paste the back discovery, continue 2 courses of treatment, the effect is showing after 3 courses of treatment, can normal life.
Typical case 3: deng, a woman in 39 years old, and a doctor visits a doctor 5/3 days in 2010, and a long-term sitting office causes cervical vertebra pain, the doctor diagnoses the cervical vertebra hyperosteogeny, the traditional Chinese medicine prepared in the embodiment 6 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on the cervical part pain, the patch is pasted one day for 12 hours every time, the treatment lasts for 4 courses of treatment, the effect is remarkable, the cervical vertebra is basically improved, and no discomfort exists.
Typical case 4: in a forest, men, age 52, visit 8 months after 2013, are engaged in physical labor for a long time, and have pain in knee joints, the treatment is performed before introduction of acquaintances, the traditional Chinese medicine prepared in the embodiment 4 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on the pain part of the knee, the patch is pasted one day for 12 hours every time, the effect is remarkable, the knee joints are basically improved, the pain is basically avoided, and the normal dry work can be performed.
Typical case 5: zhao, a woman is 68 years old, and the woman has been treated in 2015 for 26 days, the treatment is retired, lumbar hyperosteogeny is caused due to overstrain in young age, many treatment sites are not cured, and the treatment is introduced by the mature people.
Typical case 6: wangzhi, male, 37 years old, visit 13 days 2 months in 2017, work on the building site for a long time, waist fatigue is excessive, lumbar hyperosteogeny is caused, medicine taking physical therapy is not improved, the treatment is introduced by the mature people, the traditional Chinese medicine prepared in the embodiment 7 is adopted for treatment, the traditional Chinese medicine is pasted on a patch carrier, the patch is pasted on a waist pain part one day, 15 hours are pasted every time, 3 courses of treatment are insisted, the effect is remarkable, the waist basically improves, the pain is basically avoided, and normal activities can be realized.
In conclusion, the traditional Chinese medicine prepared by the embodiment of the invention has an obvious effect on patients with hyperosteogeny, can relieve pain and has a better treatment effect, and because the components used in the adopted formula belong to relatively cheap medicinal materials, the treatment expense of the patients can be reduced.
The embodiments described above are some, but not all embodiments of the invention. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

Claims (10)

1. The traditional Chinese medicine for treating the hyperosteogeny is characterized by being prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit 140 and other materials.
2. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, which is prepared from the following raw material medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white spirit.
3. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, is characterized by being prepared from the following raw medicines in parts by weight: 50-70 parts of clematis root, 20-30 parts of divaricate saposhnikovia root, 20-30 parts of borneol, 30-40 parts of szechuan lovage rhizome, 10-25 parts of ternate buttercup root, 20-30 parts of erythrina bark, 25-40 parts of cyrtomium rhizome, 10-30 parts of garden balsam stem, 10-15 parts of Sichuan pepper, 10-30 parts of seed of Chinese wampee, 40-50 parts of artificial musk, 20-35 parts of raw nux vomica, 40-50 parts of malaytea scurfpea fruit, 30-40 parts of obscured homalomena rhizome, 15-35 parts of frankincense and 200 parts of white spirit.
4. The traditional Chinese medicine for treating hyperosteogeny according to claim 3, is characterized by being prepared from the following raw medicines in parts by weight: 60 parts of clematis root, 30 parts of divaricate saposhnikovia root, 22 parts of borneol, 36 parts of szechuan lovage rhizome, 20 parts of ternate buttercup root, 25 parts of erythrina bark, 30 parts of cyrtomium rhizome, 23 parts of garden balsam stem, 12 parts of pricklyash peel, 25 parts of seed of Chinese yam, 43 parts of artificial musk, 28 parts of raw nux vomica, 46 parts of malaytea scurfpea fruit, 38 parts of obscured homalomena rhizome, 25 parts of frankincense and 160 parts of white.
5. The traditional Chinese medicine for treating hyperosteogeny according to claim 1, wherein the white spirit is 60-65 alcohol.
6. A method for preparing the traditional Chinese medicine for treating hyperosteogeny according to any one of the claims 1 or 3, which comprises the following steps:
weighing the medicines: weighing the raw material medicines according to the proportion of the formula;
crushing: pulverizing the raw materials except Chinese liquor to obtain raw medicinal powder;
mixing: mixing the raw material powder obtained in the crushing step with the white spirit, and uniformly stirring to obtain a mixture;
sealing: placing the mixture prepared in the mixing step in a closed container for sealed storage;
and (3) patent medicine preparation: taking out the sealed mixture to obtain the traditional Chinese medicine.
7. The method according to claim 6, wherein the raw materials are subjected to impurity removal, screening, washing, drying and baking before the crushing step.
8. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein the size of the raw material powder crushed in the crushing step is 80-200 meshes.
9. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein the mixing speed in the mixing step is 70-80r/min, and the mixing time is 10-30 min.
10. The method for preparing a Chinese medicinal composition for treating hyperosteogeny according to claim 6, wherein said sealing step comprises hermetically storing the mixture in a sealed container for 3 months, and stirring the mixture in the container at a speed of 70-80r/min for 1-5min by opening the container at 1-month intervals.
CN202110034417.XA 2021-01-11 2021-01-11 Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof Pending CN112603957A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110034417.XA CN112603957A (en) 2021-01-11 2021-01-11 Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110034417.XA CN112603957A (en) 2021-01-11 2021-01-11 Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112603957A true CN112603957A (en) 2021-04-06

Family

ID=75253851

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110034417.XA Pending CN112603957A (en) 2021-01-11 2021-01-11 Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112603957A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1285196A (en) * 2000-08-28 2001-02-28 赵芳可 Shubi plaster for treating arthralgia due to wind-cold-dampness
CN101905007A (en) * 2010-07-09 2010-12-08 徐利华 Plaster for curing rheumatoid pains in neck, shoulders, waist and legs
CN102266541A (en) * 2011-07-11 2011-12-07 谢书芳 Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1285196A (en) * 2000-08-28 2001-02-28 赵芳可 Shubi plaster for treating arthralgia due to wind-cold-dampness
CN101905007A (en) * 2010-07-09 2010-12-08 徐利华 Plaster for curing rheumatoid pains in neck, shoulders, waist and legs
CN102266541A (en) * 2011-07-11 2011-12-07 谢书芳 Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
曹静: "消刺膏治疗骨质增生46例", 《中医外治杂志》 *

Similar Documents

Publication Publication Date Title
CN104644943A (en) Traditional Chinese medicine composition, medicinal moxibustion containing same and preparation method
CN112717103A (en) Plant liquid for treating neck, shoulder, waist and leg pain
CN112915173A (en) Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application
CN112603957A (en) Traditional Chinese medicine for treating hyperosteogeny and preparation method thereof
CN103301401B (en) A kind of medicated wine and preparation method thereof
CN104623432B (en) A kind of Chinese medicine composition for treating tumour
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN113082103A (en) Traditional Chinese medicine composition for treating traumatic injury and sprain and preparation method thereof
CN113476577A (en) A Chinese medicinal composition for treating rheumatic arthralgia and traumatic injury, and its preparation method
CN1054521C (en) External use medicine bag for treatment of woman dysmenorrhea and its making method
CN110279746A (en) A kind of massage cream and preparation method thereof for treating traumatic injury
CN115998829B (en) Chinese medicinal powder for treating pain and application method thereof
CN107213347A (en) It is a kind of to treat orthopaedics bone-set plaster of fracture and preparation method thereof
CN106729065A (en) Fuling peel folium artemisiae argyi sweet basil moxibustion post
CN105560477A (en) Meridian and collateral dredging hot compress salt and preparation method thereof
CN104873847A (en) Traditional Chinese medicine lotion for alleviating local swelling and pain caused by soft tissue injury and preparation method of traditional Chinese medicine lotion
CN111419924A (en) A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device
CN112107669A (en) A Chinese medicinal composition for treating arthritis and synovitis, and its preparation method
CN110585290A (en) Swelling eliminating patch for promoting blood circulation to arrest pain and preparation method thereof
CN115969948A (en) Dampness-clearing navel plaster formula and preparation method thereof
CN116492444A (en) A Chinese medicinal composition for improving multiple sub-health symptoms, and its preparation method
CN116832102A (en) Musk chain traditional Chinese medicine formula with wind-dispelling and cold-dispelling functions and preparation method thereof
CN115429844A (en) Medicinal liquor for treating arthralgia
CN117562944A (en) Medicine for treating lumbar paralysis
CN113855752A (en) A Chinese medicinal composition for treating osteoarticular diseases, and its preparation method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210406

RJ01 Rejection of invention patent application after publication